Zinc Carnosine
Mucosa-protecting zinc complex for ulcers and gut-lining repair.
What is Zinc Carnosine?
Zinc Carnosine (Polaprezinc) is a gut and immune supplement used for heal gastric ulcers. NutriDex grades the human evidence as Moderate. Zinc carnosine (polaprezinc) is a chelate of zinc and L-carnosine that adheres to damaged mucosa, where it acts as an antioxidant and stimulates repair. It is an approved gastric-ulcer drug in Japan and South Korea. In a multicentre RCT, 8 weeks of 150 mg/day matched rebamipide for ulcer healing (~81% effective). A meta-analysis of RCTs found adding it to standard triple therapy roughly doubled H. pylori eradication odds (OR ~2.0 intention-to-treat) without extra side effects. Randomised trials in cancer patients show it markedly cuts severe oral mucositis from radio/chemotherapy, and a small crossover study found it blunted NSAID-induced rises in gut permeability. A pooled analysis also confirms it raises serum zinc and corrects deficiency. Limits: most trials are small, short, single-region, and often test it as an add-on, so the size of any stand-alone benefit for general 'gut health' is uncertain.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Gastric ulcer healingOne multicentre double-blind RCT (n=224) showed ~81% healing, non-inferior to rebamipide; single trial, 8 weeks only. | Moderate | ↑ benefit · moderate | 1 |
| H. pylori eradication (as add-on to triple therapy)Meta-analysis of RCTs roughly doubled eradication odds (ITT OR 2.01); benefit is as an add-on, not standalone. | Moderate | ↑ benefit · moderate | 2 |
| Oral mucositis from radio/chemotherapySingle RCT in HSCT patients cut grade greater-or-equal 2 mucositis to 20% vs 82%; striking but small, single-study. | Preliminary | ↑ benefit · large | 1 |
| Gut barrier protection (NSAID-induced permeability)One small crossover trial in healthy adults blunted indomethacin-induced permeability rise; not a general gut-health endpoint. | Preliminary | ↑ benefit · moderate | 1 |
| Correcting zinc deficiency (raising serum zinc)IPD dose-response meta-analysis raised serum zinc by mean 9.08 ug/dL with dose-response; modest absolute increase. | Moderate | ↑ benefit · small | 1 |